Analyze the earnings history of Apellis Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | APLS | Q1 | -$1.56 | -$0.54 | — | — | $44.85M | $161.51M | — | — | Get Alert |
02/27/2024 | AM | APLS | Q4 | -$1.50 | -$0.69 | -$0.73 | -5.80% | $22.66M | $143.59M | $146.38M | 1.94% | Get Alert |
11/01/2023 | AM | APLS | Q3 | -$1.75 | -$0.85 | -$1.17 | -37.65% | $22.06M | $99.74M | $110.40M | 10.69% | Get Alert |
07/31/2023 | AM | APLS | Q2 | -$1.46 | -$1.32 | -$1.02 | 22.73% | $16.32M | $70.25M | $94.97M | 35.19% | Get Alert |
05/04/2023 | PM | APLS | Q1 | -$1.42 | -$1.46 | -$1.56 | -6.85% | $14.38M | $26.10M | $44.85M | 71.82% | Get Alert |
02/21/2023 | PM | APLS | Q4 | -$1.61 | -$1.57 | -$1.50 | 4.46% | $60.29M | $24.19M | $22.66M | -6.31% | Get Alert |
11/07/2022 | PM | APLS | Q3 | -$1.57 | -$1.45 | -$1.75 | -20.69% | $5.65M | $21.59M | $22.06M | 2.16% | Get Alert |
08/08/2022 | PM | APLS | Q2 | -$2.72 | -$1.36 | -$1.46 | -7.35% | $623.00K | $16.94M | $16.32M | -3.65% | Get Alert |
05/04/2022 | PM | APLS | Q1 | -$2.32 | -$1.32 | -$1.42 | -7.58% | $0.00 | $12.57M | $14.38M | 14.41% | Get Alert |
02/28/2022 | PM | APLS | Q4 | $0.93 | -$1.54 | -$1.61 | -4.55% | $250.00M | $8.78M | $60.29M | 586.67% | Get Alert |
11/08/2021 | PM | APLS | Q3 | -$1.79 | -$1.75 | -$1.57 | 10.29% | $646.00K | $7.22M | $5.65M | -21.75% | Get Alert |
08/09/2021 | PM | APLS | Q2 | -$1.57 | -$1.70 | -$2.72 | -60.00% | $0.00 | $810.00K | $623.00K | -23.09% | Get Alert |
04/28/2021 | PM | APLS | Q1 | -$2.29 | -$1.62 | -$2.32 | -43.21% | $0.00 | $2.27M | $0.00 | -100.00% | Get Alert |
02/25/2021 | PM | APLS | Q4 | -$1.77 | — | $0.93 | — | $0.00 | $96.09M | $250.00M | 160.17% | Get Alert |
11/02/2020 | AM | APLS | Q3 | -$1.09 | — | -$1.79 | — | $0.00 | — | $646.00K | — | Get Alert |
07/31/2020 | AM | APLS | Q2 | -$1.12 | — | -$1.57 | — | $0.00 | — | $0.00 | — | Get Alert |
04/29/2020 | PM | APLS | Q1 | -$0.87 | — | -$2.29 | — | $0.00 | — | $0.00 | — | Get Alert |
02/27/2020 | PM | APLS | Q4 | -$0.65 | — | -$1.77 | — | $0.00 | — | $0.00 | — | Get Alert |
11/05/2019 | AM | APLS | Q3 | -$0.64 | — | -$1.09 | — | $0.00 | — | $0.00 | — | Get Alert |
Apellis Pharmaceuticals (APLS) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $-0.73, which missed the estimate of $-0.69.
The Actual Revenue was $146.4M, which beat the estimate of $143.6M.
Browse earnings estimates, EPS, and revenue on all stocks.